Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?-Reference-Cited by-同舟云学术

Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?

Published:2013-01-18 Issue:6 Volume:57 Page:2180-2188
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

van der Poorten David,Samer Caroline F.,Ramezani-Moghadam Mehdi,Coulter Sally,Kacevska Marina,Schrijnders Dennis,Wu Lindsay E.,McLeod Duncan,Bugianesi Elisabetta,Komuta Mina,Roskams Tania,Liddle Christopher,Hebbard Lionel,George Jacob

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26072/fullpdf

Reference42 articles.

1. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings;Brunt;HEPATOLOGY,2011

2. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions;Brunt;Am J Gastroenterol,1999

3. Design and validation of a histological scoring system for nonalcoholic fatty liver disease;Kleiner;HEPATOLOGY,2005

4. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

5. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation;Ayata;Hum Pathol,2002

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parámetro de atenuación ultrasonográfica por elastografía transitoria 1D en pacientes con hepatopatía crónica;Revista GEN;2024-08-05

2. Metabolic dysfunction‐associated steatohepatitis exhibits sex differences in people with HIV;HIV Medicine;2024-08

3. Clinical performance of ultrasonic backscatter parametric and nonparametric statistics in detecting early hepatic steatosis;Ultrasonics;2024-08

4. The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease;Annals of Hepatology;2024-07

5. Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes;Obesity Science & Practice;2024-07